Marker Therapeutics, Inc. ( MRKR) - Key Metrics
MRKR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.09 | -$0.19 | -$0.19 |
| 2026Q1 | $0 | -$0.16 | -$0.07 | -$0.07 |
| 2025Q4 | $0 | -$0.11 | -$0.12 | -$0.12 |
| 2025Q3 | $0.07 | -$0.12 | -$0.16 | -$0.16 |
| 2025Q2 | $0.06 | -$0.29 | -$0.13 | -$0.13 |
MRKR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.68 |
| 2026Q1 | 0% | -2.03 |
| 2025Q4 | 0% | -3.72 |
| 2025Q3 | 0% | -1.86 |
| 2025Q2 | 0% | -1.32 |
MRKR
Price: $1.15
52 week price:
Earnings Per Share: -0.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 156064
Market Capitalization: 19.2 million